Novel Stool RNA Test More Sensitive for Detecting Colon Cancer Versus FIT
(MedPage Today) -- VANCOUVER, British Columbia -- The novel multitarget stool RNA test (ColoSense) showed high sensitivity for detecting colorectal neoplasia among adults ages 45 and older, according to the phase III prospective CRC-PREVENT trial...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Gastroenterology | UK Health